Fuller & Thaler Asset Management
IART icon

Fuller & Thaler Asset Management’s Integra LifeSciences IART Stock Holding History

Fuller & Thaler Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2M Sell
3,529,404
-106,956
-3% -$1.17M 0.11% 235
2025
Q4 		$45.2M Sell
3,636,360
-278,078
-7% -$3.7M 0.15% 211
2025
Q3 		$56.1M Buy
3,914,438
+21,906
+0.6% +$300K 0.19% 177
2025
Q2 		$47.8M Sell
3,892,532
-29,987
-0.8% -$435K 0.17% 193
2025
Q1 		$86.3M Sell
3,922,519
-9,760
-0.2% -$229K 0.34% 101
2024
Q4 		$89.2M Sell
3,932,279
-35,283
-0.9% -$770K 0.34% 98
2024
Q3 		$72.1M Buy
3,967,562
+2,125,647
+115% +$49.3M 0.28% 120
2024
Q2 		$53.7M Buy
1,841,915
+1,401,045
+318% +$41.6M 0.23% 137
2024
Q1 		$15.6M Sell
440,870
-400,189
-48% -$16M 0.07% 252
2023
Q4 		$36.6M Buy
841,059
+235,565
+39% +$9.27M 0.19% 156
2023
Q3 		$23.1M Sell
605,494
-56,669
-9% -$2.38M 0.13% 174
2023
Q2 		$27.2M Sell
662,163
-847,220
-56% -$40.8M 0.15% 163
2023
Q1 		$86.7M Sell
1,509,383
-3,269
-0.2% -$184K 0.5% 73
2022
Q4 		$84.8M Buy
1,512,652
+713,454
+89% +$36.3M 0.54% 65
2022
Q3 		$33.9M Sell
799,198
-556
-0.1% -$28.5K 0.24% 130
2022
Q2 		$43.2M Sell
799,754
-2,970
-0.4% -$178K 0.3% 112
2022
Q1 		$51.6M Buy
802,724
+98,702
+14% +$6.5M 0.31% 111
2021
Q4 		$47.2M Buy
704,022
+109,220
+18% +$7.39M 0.27% 117
2021
Q3 		$40.7M Buy
594,802
+294,052
+98% +$20.8M 0.26% 114
2021
Q2 		$20.5M Buy
300,750
+14,554
+5% +$1.03M 0.13% 150
2021
Q1 		$19.8M Buy
286,196
+1,651
+0.6% +$112K 0.14% 153
2020
Q4 		$18.5M Buy
284,545
+206,260
+263% +$11.1M 0.17% 142
2020
Q3 		$3.7M Buy
78,285
+242
+0.3% +$11.5K 0.05% 244
2020
Q2 		$3.67M Sell
78,043
-67,422
-46% -$3.31M 0.05% 240
2020
Q1 		$6.5M Buy
145,465
+968
+0.7% +$50.8K 0.11% 172
2019
Q4 		$8.42M Buy
144,497
+1,395
+1% +$83K 0.09% 175
2019
Q3 		$8.6M Buy
143,102
+31,449
+28% +$1.87M 0.1% 167
2019
Q2 		$6.24M Buy
+111,653
New +$5.75M 0.07% 193

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fuller & Thaler Asset Management's IART Position: Q1 2026 in Review

Fuller & Thaler Asset Management reduced its Integra LifeSciences (IART) stake by 2.9% in Q1 2026, selling an estimated $1.17M and leaving 3,529,404 shares worth $33.2M. The position accounts for 0.11% of the portfolio, ranked #235.

Fuller & Thaler Asset Management first reported a position in IART in Q2 2019 and has held it in 28 quarters since. The position peaked at $89.2M in Q4 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Fuller & Thaler Asset Management held 3,529,404 shares of Integra LifeSciences worth $33.2M as of Q1 2026.
  • Fuller & Thaler Asset Management sold 106,956 Integra LifeSciences shares in Q1 2026, an estimated $1.17M.
  • Integra LifeSciences made up 0.11% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #235 holding.
  • Fuller & Thaler Asset Management first reported a position in Integra LifeSciences in Q2 2019 and has held it in 28 quarters since.
  • Fuller & Thaler Asset Management's Integra LifeSciences position peaked at $89.2M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.